Due to the current development of the COVID-19 pandemic the conference will take place online now. We are very sorry not to meet you in Konzerthaus Freiburg as originally planned, but very much look forward to welcoming you to an interactive virtual event.
The online conference programme has been published below and the online registration is open now. Authors can prepare their lecture/poster presentation according to the instructions.
| Delegates | Members2) | Others |
|---|---|---|
| Industry | 330 € | 345 € |
| Academia | 225 € | 240 € |
| Students3) | 105 € | 120 € |
1) No VAT requested according to § 4.22 UStG
2) Personal DECHEMA-, VDI-GVC-members and EFC/EFCE passport holders; personal VAAM members
3) Become part of the DECHEMA network for students, PhD students and young professionals from chemistry, biotechnology and related fields of study and topics. The DECHEMA membership is free of charge for master, bachelor and PhD students.
Please note that registration fee cannot be waived for authors. register now
The DECHEMA terms and conditions for conferences apply. Please note that the following information are exerpts and supplements to the general terms and conditions.
Registration is possible up to the beginning of the conference. Once the booking has been processed, the participant is sent confirmation and an invoice.
Editorial deadline for the list of participants is 12 April 2021.
The registration fees include conference ticket, book of abstracts and the list of participants as PDF files.
With your registration for participation, you agree that DECHEMA may pass on your contact details (title, first name, surname, institution, city, country, e-mail) to those exhibitors whose virtual exhibition stands you visit.
Cancellations are only accepted in writing (i.e. by fax, surface mail or e-mail).
Please find details about cancellation dates and fees in the general terms and conditions. In case of no-show the conference fees won't be refunded and fees not yet paid still have to be paid.
We are pleased to announce renowned keynote speakers (as of February 2021):
Application of microphysiological systems to drug safety assessment: progress and challenges
Rhiannon David, AstraZeneca, Cambridge/UK
Advancing regulatory science through innovation; in vitro microphysiological systems
Suzanne C. Fitzpatrick, CFSAN/FDA, College Park Maryland, MD/USA
Synthetic biology-inspired cell-based treatment strategies of the future
Martin Fussenegger, ETH Zurich/CH
Organotypic 3D models to characterize the molecular requirements of immune cell infiltration and activation
Wolfgang Sommergruber, University of Applied Sciences, Vienna/A
(subject to change, as of February 2021)
Wednesday, 5 May 2021
| 10:00 |
Opening and Technical Remarks |
|---|---|
Synthetic Biology, Screening Platforms and Metabolomics
|
|
| 10:10 |
Keynote Lecture 1
Synthetic biology-inspired cell-based treatment strategies of the futureM. Fussenegger¹; ¹ ETH Zurich/CH |
| 10:40 | Advanced in vitro management of three-dimensional cell cultures and explanted tissue S. Kreß¹; D. Egger¹; C. Kasper¹ ¹ University of Natural Resources and Life Sciences (BOKU), Vienna/A |
| 10:55 |
Label-free measurements of the metabolic activity within 3D cell culture model via automated 3D microphysiometry |
| 11:10 |
P2.2.04 Hypoxia or normoxia: mesenchymal stem cells and chondrocytes with a genetically integrated hypoxia sensor in different 3D cell culture systems |
| 11:15 |
EU-OPENSCREEN: A novel collaborative model for accelerating early phase drug discovery |
| 11:30 | Discussion with all speakers of this session |
| 11:45 | Lunch Break |
Advanced 3D Models for Tumor ResearchChair: J.M. Kelm, PreComb Therapeutics AG, Wädenswil/CH |
|
| 13:30 |
Keynote Lecture 2
Organotypic 3D models to characterize the molecular requirements of immune cell infiltration and activationW. Sommergruber¹; A. Osswald²; I. Voelkl³; V. Hedrich³; A. Rudisch³; N. Harrer³; M. Dong⁴; H. van der Kuip⁴; A. Wernitznig³; A. Bernthaler³; J. Lipp³; S. Rebelo⁵; C. Pinto³; C. Brito⁵; S. Hall⁶ ¹ University of Applied Sciences Vienna/A; ² Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/D; ³ Boehringer Ingelheim RCV GmbH & Co KG, Vienna/A; ⁴ University of Tuebingen/D; ⁵ iBET, Universidede Nova de Lisboa/P; ⁶ University Hospital Bern/CH |
| 14:00 |
Development of a 4D-in vitro-test system for specificity and potency of 3rd generation chimeric antigen receptor-T-cells (CAR-T-cells) based on microcavity array-bioreactors ² University Hospital Heidelberg/D |
| 14:15 |
3D modelling of the chronic lymphocytic leukaemia microenvironment |
| 14:30 | Targeting the fibrotic tumor microenvironment: Novel 3D co-culture organoids for pancreatic adenocarcinoma (PDAC) drug discovery J. Hänsel¹; K. Peter¹; T. Kurz²; R. Mrsny³; N. Teusch¹ ¹ Universität Osnabrück/D; ² Heinrich-Heine-Universität Düsseldorf/D; ³ University of Bath/UK |
| 14:45 |
P3.3.01 Generation of multicellular spheroid culture models of pediatric vital tumor samples obtained through the INFORM registry study for functional studies |
| 14:50 | Discussion with all speakers of this session |
| 15:05 |
Poster Session 1 / Exhibition |
| 16:45 |
End of Day 1 |
|
17:00 -18:00 |
Section Member Assembly DECHEMA Sections "Cell Culture Technology" and "Medical Biotechnology" |
Complex and Multi-Celltype ModelsChair: C. Kasper, University of Natural Resources and Life Sciences, Vienna/A |
|
| 09:00 |
Image based quantification of myeloid cell repolarization and their interplay within the tumor microenvironment in 3D |
| 09:15 | Application of ultrasmall gold nanoparticles (2 nm) in a 3D blood-brain-barrier in vitro model V. Sokolova¹; G. Mekky²; S. van der Meer¹; M. Seeds³; A. Atala³; M. Epple¹ ¹ University of Duisburg-Essen, Essen/D; ² Zagazig University/ET; ³ Wake Forest School of Medicine, Winston-Salem, NC/USA |
| 09:30 |
Manufacturing of functional beta cell-mesenchymal stem cell-spheroids for transplantation or drug testing ² University of Giessen/D |
| 09:45 | Assembly of multi-spheroid cellular architectures by programmable droplet merging H. Cui¹; A. Popova¹; P. Levkin¹ ¹ Karlsruher Institut für Technologie (KIT), Eggenstein-Leopoldshafen/D |
| 10:00 |
P1.2.01 Development of a new human organotypic 3D urinary bladder epithelium model in complex whole blood co-culture with immune cells |
| 10:05 |
Discussion with all speakers of this session |
| 10:20 |
Coffee Break |
Innovative Microphysiological Systems IChair: U. Marx, TissUse GmbH, Berlin/D |
|
| 11:00 |
Keynote Lecture 3
Application of microphysiological systems to drug safety assessment: progress and challengesR. David¹; ¹ AstraZeneca, Cambridge/UK |
| 11:30 | OncoChip - A novel microfluidic platform for compound efficacy testing on human 3D microtumors M. Pawlak¹; S. Yüz²; B. Gierke¹; J. Hofmann³; U. Härle²; S. Werner²; B. Hagmeyer²; Z. von Guttenberg³; M. Stelzle²; C. Schmees² ¹ NMI TT Pharmaservices, Reutlingen/D; ² NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen/D; ³ ibidi GmbH, Gräfelfing/D |
| 11:45 |
P2.1.02 Applying a microphysiological 3D human liver – islet microtissue platform to study drug – drug interaction |
| 11:50 |
P1.1.07 |
| 11:55 |
Discussion with all speakers of this session |
| 12:10 |
Lunch Break |
| 13:30 |
Poster Session 2 / exhibition |
Innovative microphysiological systems IIChair: J. Hansmann, Universitätsklinikum Würzburg/D |
|
| 15:00 |
Keynote Lecture 4
Advancing regulatory science through innovation; in vitro microphysiological systemsS. Fitzpatrick¹ ¹ Center for Food Safety and Applied Nutrition / FDA, College Park, MD/USA |
| 15:30 | A human immuno-competent microphysiological alveolus-on-chip model to study microbial pathogenesis K. Rennert¹; S. Deinhardt-Emmer²; E. Schicke²; Z. Cseresnyés³; S. Nietzsche²; M. Raasch¹; G. Makert dos Santos⁴; S. Ulbert⁴; P. Loskill⁵; C. Ehrhardt²; B. Löffler²; A. Mosig² ¹ Dynamic42 GmbH, Jena/D; ² University Hospital Jena/D; ³ Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (HKI), Jena/D; ⁴ Fraunhofer Institute for Cell Therapy and Immunology, Leipzig/D; ⁵ Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart/D |
| 15:45 | Micro-physiological system for prolonged cultivation of immune competent lung tissue ex vivo S. Böhlen¹; S. Konzok¹; S. Behrens²; F. Schmieder²; F. Sonntag²; A. Braun¹; S. Dehmel¹; K. Sewald¹ ¹ Fraunhofer Institute for Toxicology and Experimental Medicine ITEM & Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH), Hanover/D; ² Fraunhofer Institute for Material and Beam Technology IWS Dresden/D |
| 16:00 |
P3.1.01 Development of vascularized melanoma skin equivalents for studying metastasis and anti-melanoma therapies |
| 16:05 |
Discussion with all speakers of this session |
| 16:20 |
Award Ceremony
|
| 16:45 |
Virtual Get Together at wonder (www.wonder.me)
|
| 17:45 |
End of Day 2 |
Investigating Host-Microbial InteractionsChair: I. Prade, Forschungsinstitut für Leder und Kunststoffbahnen (FILK) gGmbH, Freiberg/D |
|
| 09:00 | Microengineered in vitro model of the small intestine epithelium for studying host-bacteria interactions M. García-Díaz¹; M. Cendra¹; R. Alonso-Román¹; E. Torrents¹; E. Martínez¹ ¹ Institute for Bioengineering of Catalonia (IBEC), Barcelona/E |
| 09:15 | Matrix-free culture of intestinal organoids in thermoformed microwells P. Kakni¹; S. Giselbrecht¹; R. Truckenmüller¹; P. Habibovic¹ ¹ Maastricht University/NL |
| 09:30 | Investigating human cytomegalovirus infection in human vessels based on novel in vitro and in vivo model systems A. Dittrich¹; I. Kutle¹; D. Wirth¹ ¹ Helmholtz Centre for Infection Research, Braunschweig/D |
| 09:45 |
Discussion with all speakers of this session |
| 10:00 |
Coffee Break |
Bioprinting and Enabling TechnologiesChair: M. Rimann, Zurich University of Applied Sciences, Wädenswil/CH |
|
| 10:30 | Fabrication of human jawbone models using stereolithographic 3D bioprinting A. Amler¹; A. Thomas¹; T. Lam²; M. Geiger²; A. Kreuder¹; C. Palmer²; S. Nahles³; R. Lauster¹; L. Kloke² ¹ TU Berlin/D; ² Cellbricks GmbH, Berlin/D; ³ Charite Universitätsmedizin Berlin/D |
| 10:45 | Tissue brick macro-scale organ engineering for trabecular heart design R. Lensing¹; K. Pfannkuche²; A. Schmidt³; E. Bremus-Köbberling⁴; N. Nottrodt⁴ ¹ RWTH Aachen University/D; ² University Hospital Cologne/D; ³ University of Cologne/D; ⁴ Fraunhofer Institute for Laser Technology, Aachen/D |
| 11:00 | Drop-on-demand bioprinting solutions for the fabrication of 3D cell culture systems aiming for in vitro screening applications K. Tröndle¹; A. Itani¹; F. Koch¹; R. Zengerle²; P. Koltay¹; S. Zimmermann¹ ¹ University of Freiburg/D; ² Hahn-Schickard, Freiburg/D |
| 11:15 | Using peptide hydrogels to build 3D cell disease and tissue models for drug discovery A. Miller¹; ¹ University of Manchester/UK |
| 11:30 | Discussion with all speakers of this session |
| 11:45 | Closing Remarks |
| 11:50 | End of the Conference |
Please select "Poster" for the "Form of Presentations". Poster authors can find the new poster numbers here.
The online exhibition offers a good opportunity to promote your technologies products, and services in the 3D cell culture field.
Book your Exhibition Package through the button below or contact the Conference Office for further information.
Standard Exhibition Package (800 € + VAT)
In the Virtual Venue:
On the event website:
Option to book 1 additional conference participation for a reduced fee of 190 €.
Dear lecture and poster authors, please note: Registration fee cannot be waived for authors. Please register online. If you are unable to present your lecture or poster for any reason, please let us know immediately.
The official language of the conference is English.
As an online meeting platform we use Converia's Virtual Venue and ZOOM. We recommend to download the ZOOM APP to share your presentation. We are planning test runs in the week before the conference. The detailed information will be sent to you in due time.
It is recommended to use Google Chrome or Firefox as your browser.
Keynote lecture is planned for a 25 min talk plus 5 min discussion (totally 30 min).
Lecture from Call for Papers is planned for a 14 min talk plus 1 min discussion (totally 15 min).
Poster lecture is planned for 5 min talk with 5 slides (totally 5 min).
At end of each session 15 min are planned for discussion with all speakers of the session.
Strict timekeeping will be essential for the smooth running of the conference.
Please prepare your slides in 16:9 format.
In case that you use special software for your presentation or if you have videos included into your file, please notify the conference secretariat in advance.
To see how to prepare the content and what requirements does a PDF E-Poster need to meet to be correctly displayed, please download the poster instruction.
The UPLOAD OF YOUR E-POSTER ends on 15 April 2021.
Please log in at https://dechema.converia.de/frontend/index.php?sub=486, click on "View submitted papers/sessions". Click "Actions" then you have the possibility to upload your e-poster in PDF format under "Upload or edit presentation".
The E-Posters will be shown throughout the whole online conference.
Poster session I takes place on 5 May, 3.05 - 4.45 p.m.
Poster session II takes place on 6 May, 1.30 - 3 p.m.
The poster authors are requested to be present at their ePoster during the poster sessions for Q&A.
Florian Fuchs, NUVISAN ICB GmbH, Berlin/D
Jan Hansmann, Universitätsklinikum Würzburg/D
Hansjörg Hauser, Helmholtz Centre for Infection Research, Braunschweig/D
Cornelia Kasper, University of Natural Resources and Life Sciences, Vienna/A
Jens M. Kelm, PreComb Therapeutics AG, Wädenswil/CH
Uwe Marx, TissUse GmbH, Berlin/D
Tobias May, InSCREENeX GmbH, Braunschweig/D
Ralf Pörtner, Hamburg University of Technology/D
Ina Prade, Forschungsinstitut für Leder und Kunststoffbahnen (FILK) gGmbH, Freiberg/D
Markus Rimann, Zurich University of Applied Sciences, Wädenswil/CH
Heinz Ruffner, Novartis Institutes for BioMedical Research, Basel/CH
Karin Tiemann, DECHEMA e. V., Frankfurt am Main/D
The topics of the 3D Cell Culture 2021 are as follow:
• Advanced models for substance testing
• Innovative disease models
• Multi-cell type models
• Deviations from 3D models to the patient
• Microphysiological and multi-organ technologies
• New devices for 3D cell culture
• Advanced imaging technologies
• High-throughput and automation
• 3D printing
• Bioinformatics, systems biology, modelling
• 3D models for therapies
• Prediction of drug efficacy and safety
• Precision medicine
• Translation of models to solutions
• Regulatory aspects
• 3D models to investigate infectious diseases
The 3D Cell Culture 2021 conference will focus on advanced and predictive 3D cell culture models for the understanding of diseases and substance testing. This includes complex systems like multi-cell type models, multi-organ and microphysiological systems.
The successful development and application of 3D cell culture relies on innovative enabling technologies like new devices, printing and imaging technologies, analytical tools, high-throughput and automatisation.
A key question is the successful translation of models to clinical and industrial applications. What are the success stories? How can 3D models be used to predict therapies or to investigate infectious diseases? Where are the hurdles, also in the regulatory context?
In addition to scientific presentations, the exhibition will showcase practical applications, products and solutions and further stimulate discussion between researchers, solution providers and users.
The 3D Cell Culture conference is an initiative of the DECHEMA working groups “Cell Culture Technology” and “Medical Biotechnology”
in cooperation with
 |
 |
 |
DECHEMA-Fokus-Themen:
